Dipyridamole
NDC 0641-2569, Dipyridamole, injection, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0641-2569
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074521
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0641-2569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DIPYRIDAMOLE5 mg/mL
Pharmacologic classes
Decreased Platelet Aggregation [PE]; Platelet Aggregation Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0641-2569-44 | 00641256944 | 5 VIAL in 1 CARTON (0641-2569-44) / 10 mL in 1 VIAL (0641-2569-41) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6093dcd9-82d2-414f-8507-eda22c14f626Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0641-2569
Use it
Look up 0641-2569 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0641-2569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0641-2569. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.